Lv5
980 积分 2024-04-02 加入
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
1个月前
已完结
Re-evaluating antibody–drug conjugate linker stability: assessment, interpretation, and clinical translation
1个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1个月前
已完结
ZW191, an FRα-Targeted Topoisomerase 1 Inhibitor ADC with a Differentiated Antitumor Efficacy and Tolerability Profile
3个月前
已完结
Extracellular Vesicle–Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche That Drives Colorectal Cancer Metastasis
6个月前
已完结
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
7个月前
已完结
CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance
7个月前
已完结
Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protein Degradation Approaches
7个月前
已完结
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4–Targeted Antibody–Drug Conjugate Enfortumab Vedotin in Bladder Cancer
7个月前
已完结
Expression of canine interleukin-4 in canine chondrocytes inhibits inflammatory cascade through STAT6
7个月前
已完结